Other studies have outlined that inactivation of LSD1 by gene editing techniques could inhibit the proliferation and migration of leukemia [130, 131], Merkel cell carcinoma (MCC) [132], and HCC cells [133]. This evidence concerns the gene KDM1A and Merkel cell skin cancer.